Skye Bioscience, Inc. (SKYE) shareholders
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.09+0.01 (+0.93%)
Close on Nov 13, 2026Market cap $4.82MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
5.7%
2M of 35M shares
Institutional holders
43
7 new, 3 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 30 sales
Net sold $889.20K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Andrew J. Schwab Joint filing with 5AM Partners VII, LLC (25.70%), 5AM Ventures VII, L.P. (25.70%) and 1 more | 1,218,088 | 26.10% | 13D (active) amendment | Sep 22, 2026 |
| Tang Capital Management, LLC Joint filing with Kevin Tang (6.00%) | 263,560 | 6.00% | 13G (passive) | Oct 7, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SKYE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| 5AM Venture Management, LLC | 1,210,220 | 3.42% | $6.71M | – | 2.33% |
| Versant Venture Management, LLC | 250,963 | 0.71% | $1.39M | – | 0.86% |
| Baker Bros. Advisors LP | 196,905 | 0.56% | $1.09M | – | 0.01% |
| Vanguard Capital Management LLC | 95,485 | 0.27% | $529.37K | −72 | 0.00% |
| Sphera Funds Management Ltd. | 84,866 | 0.24% | $470.70K | – | 0.06% |
| Platinum Investment Management Ltd | 29,137 | 0.08% | $161.61K | – | 0.04% |
| BlackRock, Inc. | 29,110 | 0.08% | $161.45K | −6,657 | 0.00% |
| Geode Capital Management, LLC | 27,257 | 0.08% | $151.23K | −7,400 | 0.00% |
| Millennium Management LLC | 24,816 | 0.07% | $137.64K | −7,459 | 0.00% |
| Vanguard Fiduciary Trust Co | 13,029 | 0.04% | $72.23K | – | 0.00% |
| State Street Corp | 9,229 | 0.03% | $51.19K | −187 | 0.00% |
| UBS Group AG | 9,225 | 0.03% | $51.14K | +3,505 | 0.00% |
| Northern Trust Corp | 7,041 | 0.02% | $39.05K | +4,523 | 0.00% |
| Qube Research & Technologies Ltd | 5,385 | 0.02% | $29.87K | New | 0.00% |
| Simplex Trading, LLC | 3,372 | 0.01% | $18.70K | New | 0.00% |
| XTX Topco Ltd | 2,624 | 0.01% | $14.55K | −2,491 | 0.00% |
| Engineers Gate Manager LP | 2,524 | 0.01% | $14.00K | – | 0.00% |
| Group One Trading, L.P. | 574 | 0.00% | $3.18K | −327 | 0.00% |
| Vanguard Global Advisers, LLC | 570 | 0.00% | $3.16K | – | 0.00% |
| Morgan Stanley | 309 | 0.00% | $1.71K | −10 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 43 | 2M | 5.7% | 7 / 2 | 11 / 3 | 0M | 0M |
| Q1 2026 | 39 | 2M | 5.7% | 5 / 7 | 8 / 15 | 0M | 0M |
| Q4 2025 | 50 | 2M | 5.7% | 15 / 6 | 10 / 23 | 0M | 0M |
| Q3 2025 | 58 | 2M | 7.0% | 14 / 7 | 20 / 14 | 0M | 0M |
| Q2 2025 | 58 | 3M | 7.2% | 13 / 12 | 16 / 29 | 0M | 1M |
| Q1 2025 | 75 | 3M | 8.7% | 14 / 17 | 19 / 10 | 0M | 0M |
| Q4 2024 | 73 | 3M | 8.9% | 13 / 27 | 10 / 14 | 0M | 0M |
| Q3 2024 | 74 | 3M | 9.1% | 22 / 20 | 10 / 7 | 1M | 1M |
| Q2 2024 | 62 | 3M | 9.1% | 59 / 0 | 1 / 0 | 3M | 0M |
| Q1 2024 | 3 | 0M | 0.7% | 2 / 1 | 0 / 0 | 0M | 0M |
| Q4 2023 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Punit Dhillon | Chief Executive Officer, Director | 1,429,166 | 4.03% | Aug 7, 2026 |
| John P. Sharp | Chief Financial Officer | – | – | Apr 28, 2026 |
| Tuan Tu Diep | Chief Operating Officer | 72,833 | 0.21% | Apr 2, 2026 |
| Christopher Twitty | Chief Scientific Officer | 81,242 | 0.23% | Apr 2, 2026 |
| Puneet S. Arora | Chief Medical Officer | – | – | Feb 9, 2026 |
| Kaitlyn Arsenault | Chief Financial Officer | 167,522 | 0.47% | Feb 9, 2026 |
| Andrew J. Schwab | Director, 10% owner | 981,269 | 2.77% | Sep 24, 2026 |
| Deborah H. Charych | Director | – | – | Apr 2, 2026 |
| Paul A. Grayson | Director | 259,701 | 0.73% | Apr 2, 2026 |
| Annalisa Jenkins | Director | – | – | Apr 2, 2026 |
| Karen L. Smith | Director | – | – | Apr 2, 2026 |
| 5AM Partners VII, LLC | 10% owner | – | – | Sep 24, 2026 |
| Ventures II LP 5AM | 10% owner | 981,269 | 2.77% | Sep 24, 2026 |
| Scott M. Rocklage | 10% owner | 9,681,763 | 27.33% | Sep 24, 2026 |
| John D. Diekman | 10% owner | 9,729,505 | 27.47% | Sep 24, 2026 |
| 5AM Partners II, LLC | 10% owner | 9,305,923 | 26.27% | Sep 24, 2026 |
| 5AM Ventures VII, L.P. | 10% owner | 9,913,168 | 27.99% | Sep 24, 2026 |
| Kush Parmar | 10% owner | 1,129,348 | 3.19% | Sep 24, 2026 |
| Co-Investors Ii Lp 5am | 10% owner | 1,130,857,157 | 3192.58% | Sep 24, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ventures II LP 5AM 10% owner | Sep 23, 2026 | Sale | −114,851 | $1.61 | $184.91K | 0 |
| Ventures II LP 5AM 10% owner | Sep 23, 2026 | Sale | −4,528 | $1.61 | $7.29K | 0 |
| Andrew J. Schwab Director, 10% owner | Sep 23, 2026 | Sale | −114,851 | $1.61 | $184.91K | 0 |
| Andrew J. Schwab Director, 10% owner | Sep 23, 2026 | Sale | −4,528 | $1.61 | $7.29K | 0 |
| Ventures II LP 5AM 10% owner | Sep 22, 2026 | Sale | −27,612 | $1.65 | $45.56K | 114,851 |
| Ventures II LP 5AM 10% owner | Sep 22, 2026 | Sale | −1,088 | $1.65 | $1.80K | 4,528 |
| Andrew J. Schwab Director, 10% owner | Sep 22, 2026 | Sale | −27,612 | $1.65 | $45.56K | 114,851 |
| Andrew J. Schwab Director, 10% owner | Sep 22, 2026 | Sale | −1,088 | $1.65 | $1.80K | 4,528 |
| Andrew J. Schwab Director, 10% owner | Sep 16, 2026 | Sale | −1,285 | $1.91 | $2.45K | 5,616 |
| Andrew J. Schwab Director, 10% owner | Sep 16, 2026 | Sale | −32,607 | $1.91 | $62.28K | 142,463 |
| Kush Parmar 10% owner | Sep 16, 2026 | Sale | −32,607 | $1.91 | $62.28K | 142,463 |
| Kush Parmar 10% owner | Sep 16, 2026 | Sale | −1,285 | $1.91 | $2.45K | 5,616 |
| Andrew J. Schwab Director, 10% owner | Aug 20, 2026 | Sale | −46 | $0.32 | $15 | 55,208 |
| Andrew J. Schwab Director, 10% owner | Aug 20, 2026 | Sale | −6,495 | $0.32 | $2.08K | 7,850,155 |
| Andrew J. Schwab Director, 10% owner | Aug 20, 2026 | Sale | −1,159 | $0.32 | $371 | 1,400,560 |
| 5AM Partners II, LLC 10% owner | Aug 20, 2026 | Sale | −1,159 | $0.32 | $371 | 1,400,560 |
| 5AM Partners II, LLC 10% owner | Aug 20, 2026 | Sale | −6,495 | $0.32 | $2.08K | 7,850,155 |
| 5AM Partners II, LLC 10% owner | Aug 20, 2026 | Sale | −46 | $0.32 | $15 | 55,208 |
| Andrew J. Schwab Director, 10% owner | Aug 19, 2026 | Sale | −10,255 | $0.35 | $3.59K | 1,401,719 |
| Andrew J. Schwab Director, 10% owner | Aug 19, 2026 | Sale | −409 | $0.35 | $143 | 55,254 |
| Andrew J. Schwab Director, 10% owner | Aug 19, 2026 | Sale | −57,476 | $0.35 | $20.12K | 7,856,650 |
| 5AM Partners II, LLC 10% owner | Aug 19, 2026 | Sale | −409 | $0.35 | $143 | 55,254 |
| 5AM Partners II, LLC 10% owner | Aug 19, 2026 | Sale | −57,476 | $0.35 | $20.12K | 7,856,650 |
| 5AM Partners II, LLC 10% owner | Aug 19, 2026 | Sale | −10,255 | $0.35 | $3.59K | 1,401,719 |
| Andrew J. Schwab Director, 10% owner | Aug 18, 2026 | Sale | −45,090 | $0.38 | $17.13K | 1,411,974 |
| Andrew J. Schwab Director, 10% owner | Aug 18, 2026 | Sale | −1,830 | $0.38 | $695 | 55,663 |
| Andrew J. Schwab Director, 10% owner | Aug 18, 2026 | Sale | −253,080 | $0.38 | $96.17K | 7,914,126 |
| 5AM Partners II, LLC 10% owner | Aug 18, 2026 | Sale | −253,080 | $0.38 | $96.17K | 7,914,126 |
| 5AM Partners II, LLC 10% owner | Aug 18, 2026 | Sale | −1,830 | $0.38 | $695 | 55,663 |
| 5AM Partners II, LLC 10% owner | Aug 18, 2026 | Sale | −45,090 | $0.38 | $17.13K | 1,411,974 |
| Punit Dhillon Chief Executive Officer, Director | Aug 7, 2026 | Award | +1,090,000 | – | – | 1,419,823 |
| Andrew J. Schwab Director, 10% owner | Aug 22, 2025 | Sale | −163,979 | $3.42 | $560.81K | 1,457,064 |
| Andrew J. Schwab Director, 10% owner | Aug 22, 2025 | Sale | −6,470 | $3.42 | $22.13K | 57,493 |
| Scott M. Rocklage 10% owner | Aug 22, 2025 | Sale | −163,979 | $3.42 | $560.81K | 1,457,064 |
| Scott M. Rocklage 10% owner | Aug 22, 2025 | Sale | −6,470 | $3.42 | $22.13K | 57,493 |
| Andrew J. Schwab Director, 10% owner | Aug 21, 2025 | Sale | −2,314 | $3.57 | $8.26K | 63,963 |
| Andrew J. Schwab Director, 10% owner | Aug 21, 2025 | Sale | −58,642 | $3.57 | $209.35K | 1,621,043 |
| Scott M. Rocklage 10% owner | Aug 21, 2025 | Sale | −2,314 | $3.57 | $8.26K | 63,963 |
| Scott M. Rocklage 10% owner | Aug 21, 2025 | Sale | −58,642 | $3.57 | $209.35K | 1,621,043 |
| Kaitlyn Arsenault Chief Financial Officer | Nov 18, 2024 | Sale | −43,026 | $4.99 | $214.70K | 167,522 |
| Tuan Tu Diep Chief Development Officer | Nov 18, 2024 | Sale | −19,489 | $4.99 | $97.25K | 82,259 |
| Paul A. Grayson Director | Nov 18, 2024 | Sale | −86,244 | $4.99 | $430.36K | 259,701 |
| Punit Dhillon Chief Executive Officer, Director | Nov 18, 2024 | Sale | −82,546 | $4.99 | $411.90K | 329,823 |
| Kaitlyn Arsenault Chief Financial Officer | Nov 18, 2024 | Sale | −43,206 | $4.99 | $215.60K | 166,342 |
| Kaitlyn Arsenault Chief Financial Officer | Nov 15, 2024 | Sale | −190 | $5.55 | $1.05K | 210,548 |
| Tuan Tu Diep Chief Development Officer | Nov 15, 2024 | Sale | −85 | $5.55 | $472 | 101,748 |
| Paul A. Grayson Director | Nov 15, 2024 | Sale | −307 | $5.55 | $1.70K | 345,945 |
| Punit Dhillon Chief Executive Officer, Director | Nov 15, 2024 | Sale | −364 | $5.55 | $2.02K | 412,369 |
| Kaitlyn Arsenault Chief Financial Officer | Nov 15, 2024 | Sale | −190 | $5.55 | $1.05K | 209,548 |
| Andrew J. Schwab Director, 10% owner | Sep 13, 2024 | Sale | −11,758 | $6.06 | $71.25K | 8,167,206 |
| Andrew J. Schwab Director, 10% owner | Sep 13, 2024 | Sale | −2,000 | $6.06 | $12.12K | 1,679,685 |
| Andrew J. Schwab Director, 10% owner | Sep 13, 2024 | Sale | −79 | $6.06 | $479 | 66,277 |
| 5AM Ventures VII, L.P. 10% owner | Sep 13, 2024 | Sale | −79 | $6.06 | $479 | 66,277 |
| 5AM Ventures VII, L.P. 10% owner | Sep 13, 2024 | Sale | −2,000 | $6.06 | $12.12K | 1,679,685 |
| 5AM Ventures VII, L.P. 10% owner | Sep 13, 2024 | Sale | −11,758 | $6.06 | $71.25K | 8,167,206 |
| Andrew J. Schwab Director, 10% owner | Sep 11, 2024 | Sale | −1,440 | $6.60 | $9.50K | 66,356 |
| Andrew J. Schwab Director, 10% owner | Sep 11, 2024 | Sale | −36,504 | $6.60 | $240.93K | 1,681,685 |
| Andrew J. Schwab Director, 10% owner | Sep 11, 2024 | Sale | −214,556 | $6.60 | $1.42M | 8,178,964 |
| 5AM Ventures VII, L.P. 10% owner | Sep 11, 2024 | Sale | −36,504 | $6.60 | $240.93K | 1,681,685 |
| 5AM Ventures VII, L.P. 10% owner | Sep 11, 2024 | Sale | −214,556 | $6.60 | $1.42M | 8,178,964 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
2.92%
0M shares short
Days to cover
6.3
At 0M shares a day
Change since last report
-7.8%
From 0M shares
Short volume, 20 days
24.7%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Skye Bioscience's stock actually held short. Settlement fails (shares not delivered on time) peaked at 47,273 shares on Aug 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kaitlyn Arsenault Officer | Nov 15, 2024 | 57,084 | $314.53K | Nov 15, 2024 | Compensation |
| Paul A. Grayson Director | Nov 15, 2024 | 86,804 | $478.29K | Nov 15, 2024 | Compensation |
| Tuan Tu Diep Officer | Nov 15, 2024 | 22,877 | $126.05K | Nov 15, 2024 | Compensation |
| Punit Dhillon Officer, Director | Nov 15, 2024 | 100,693 | $554.82K | Nov 15, 2024 | Compensation |
See a number that looks wrong?